Complications of vena cava filters: a comprehensive clinical review

Cipolla, James; Weger, Natalie S.; Sharma, Rohit; Schrag, Sherwin P.; Sarani, Babak; Truitt, Michael; Lorenzo, Manuel; Sims, Carrie A.; Kim, Patrick K.; Torigian, Drew; Temple-Lykens, B.; Sicoutris, Corinna P. and Stawicki, S. Peter (2008) Complications of vena cava filters: a comprehensive clinical review. OPUS 12 Scientist, 2 (2). pp. 11-24. ISSN 1940-8633

Full text available as:

PDF (Portable Document Format) - Requires Adobe Acrobat Reader or other PDF viewer.
2205 Kb

Abstract

Deep venous thrombosis (DVT) and pulmonary embolism (PE) constitute common preventable causes of morbidity and mortality. Despite the success of aggressive prophylaxis and screening, the occurrence of DVT and/or PE is not likely to be further reduced. The traditional treatment algorithm of anticoagulation therapy has been very effective. Heparin therapy has been shown to decrease the risk of fatal PE by 75% and to reduce the risk of recurrent PE from 25% to 2%. Long-term therapy with warfarin reduces the incidence of documented DVT from 47% to 2%. However, some patients have contraindication(s) to anticoagulation or prove intolerant of therapy. For this group of patients, a vena cava filter (VCF) may be of benefit. While VCF and the techniques of VCF deployment have evolved significantly over the last four decades, significant complications related to VCF are occasionally seen. This review provides a comprehensive overview of reported VCF-related complications. Citation: Cipolla J, Weger NS, Sharma R, Schrag SP, Sarani B, Truitt M, Lorenzo M, Sims CA, Kim PK, Torigian D, Temple-Lykens B, Sicoutris CP, Stawicki SP. Complications of vena cava filters: A comprehensive clinical review. OPUS 12 Scientist 2008;2(2):11-24.

EPrint Type:Article
Uncontrolled Keywords:Vena cava filters, Complications, Morbidity and mortality, Comprehensive review, Complication prevention strategies, Safety measures, Warfarin
Subjects:Environment and Public Health > Public Health > Epidemiologic Measurements > Demography > Vital Statistics > Mortality
Respiratory Tract Diseases > Lung Diseases > Pulmonary Embolism
-Journal Repositories > OPUS 12 Scientist
Pathological Conditions, Signs and Symptoms > Pathologic Processes > Postoperative Complications
Environment and Public Health > Public Health > Epidemiologic Measurements > Demography > Vital Statistics > Morbidity
Pathological Conditions, Signs and Symptoms > Pathologic Processes > Intraoperative Complications
Equipment and Supplies > Prostheses and Implants
Cardiovascular Diseases > Vascular Diseases > Superior Vena Cava Syndrome
Cardiovascular Diseases > Vascular Diseases > Embolism and Thrombosis
Investigative Techniques > Epidemiologic Methods > Data Collection > Vital Statistics > Morbidity
Heterocyclic Compounds > Heterocyclic Compounds, 2-Ring > Benzopyrans
Investigative Techniques > Epidemiologic Methods > Data Collection > Vital Statistics > Mortality
ID Code:2906
Deposited By:Dr S. Peter Stawicki
Deposited On:09 June 2008

Archive Staff Only: edit this record